معرفی
Lasse Neukirch serves as a Guest Researcher in the Department of Biomedical Sciences at the University of Copenhagen, affiliated with both the Molecular and Translational Pharmacology and Endocrinology and Metabolism research groups. His work bridges pharmacological, endocrine, and immunological disciplines to advance cancer therapeutics through innovative translational approaches.
His research focuses on:
- Cancer Immunotherapy: Developing retrovirus-based vaccines and combination therapies targeting immune checkpoints
- Virology: Engineering endogenous retroviral vectors with modified immunosuppressive domains
- Pharmacology: Molecular mechanisms of tumor eradication through dual-pathway inhibition
- Endocrinology-Metabolism Interface: Exploring metabolic pathways in cancer progression
His 2023 Viruses publication demonstrates complete tumor eradication in mice using an endogenous retrovirus vaccine combined with anti-PD1 therapy, highlighting his translational methodology that connects virological engineering with immunological applications.
Neukirch actively contributes to the University of Copenhagen's biomedical research ecosystem through collaborations in tumor immunology and metabolic disorder studies within the Department of Biomedical Sciences.
